Edition:
United Kingdom

Rhythm Pharmaceuticals Inc (RYTM.OQ)

RYTM.OQ on NASDAQ Stock Exchange Global Market

26.26USD
16 Feb 2018
Change (% chg)

$-0.09 (-0.34%)
Prev Close
$26.35
Open
$26.38
Day's High
$26.61
Day's Low
$26.01
Volume
21,221
Avg. Vol
45,909
52-wk High
$33.80
52-wk Low
$21.38

Chart for

About

Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of peptide therapeutics for the treatment of rare genetic deficiencies that result in life-threatening metabolic disorders. The Company’s lead peptide product candidate is setmelanotide, a potent,... (more)

Overall

Beta: --
Market Cap(Mil.): $685.07
Shares Outstanding(Mil.): 27.13
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.64
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-Rhythm Pharmaceuticals Announces Progress In Clinical Development Of Setmelanotide

* RHYTHM PHARMACEUTICALS ANNOUNCES PROGRESS IN CLINICAL DEVELOPMENT OF SETMELANOTIDE FOR TREATMENT OF RARE GENETIC DISORDERS OF OBESITY

04 Jan 2018

BRIEF-Rhythm Pharmaceuticals reports Q3 loss of $1.78/shr

* Rhythm Pharmaceuticals reports third quarter 2017 financial results

14 Nov 2017

Earnings vs. Estimates